Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)
NIAMS offers R03 small grants to K01/K08/K23/K25 awardees in years 2-4 to boost research capabilities as they transition to independent investigator status; clinical trials are not allowed.
Funder: National Institutes of Health
Due Dates (Anticipated): October 2025 | October 2026
Funding Amounts: Small grants (R03 mechanism); typical total direct costs up to $50,000 per year for up to 2 years (projected based on standard NIH R03 policy).
Summary: Provides NIAMS K01, K08, K23, and K25 recipients with supplemental small grant support to advance research independence; clinical trials are not allowed.
Key Information: Limited competition; only eligible K awardees in NIAMS mission areas may apply.
Description
This forecasted opportunity from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of NIH, is designed for recipients of NIAMS-supported K01, K08, K23, and K25 career development awards. It enables eligible K awardees to apply for a Small Grant (R03) during the second to fourth year of their K award, with the goal of enhancing their research capability and supporting their transition to fully independent investigator status. The R03 mechanism is intended for small, self-contained research projects, pilot and feasibility studies, secondary data analyses, or development of research methodology or technology. Clinical trials of any phase are not permitted under this program.
